Golestan University of Medical Sciences Repository

First report on infant acute urticaria after mother’s parenteral use of meglumine antimoniate (Glucantime): A case report

Mozafari, O. and Shorofi, S.A. and Yousefi, S.S. (2016) First report on infant acute urticaria after mother’s parenteral use of meglumine antimoniate (Glucantime): A case report. Iranian Journal of Public Health, 45 (9). pp. 1217-1219.

Full text not available from this repository.

Abstract

Pentavalent antimonials are still the first drug of choice for the treatment of cutaneous leishmaniasis (CL). Like other treatments, they can cause adverse reactions including musculoskeletal pain, gastrointestinal disturbances, and mild to moderate headaches. In this paper, we report the first case of an infant who developed acute urticaria after her mother’s parenteral use of meglumine antimoniate (glucantime). © 2016 Iranian Journal of Public Health. All rights reserved.

Item Type: Article
Additional Information: cited By 0
Subjects: مقالات نمایه شده محققین دانشگاه در سایت ,Web of Science ,Scopus
Divisions: UNSPECIFIED
Depositing User: GOUMS
Date Deposited: 13 Jun 2017 04:28
Last Modified: 13 Jun 2017 04:28
URI: http://eprints.goums.ac.ir/id/eprint/4903

Actions (login required)

View Item View Item